STOCK TITAN

Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Senseonics Holdings (NYSE American: SENS), a medical technology company specializing in long-term, implantable continuous glucose monitoring (CGM) systems for diabetes patients, has announced its participation in the TD Cowen 45th Annual Health Care Conference in Boston, MA.

The company will deliver a corporate overview and conduct one-on-one meetings during the conference on Tuesday, March 4, 2025, at 3:10 pm ET. Interested parties can access both live and recorded webcasts of the presentation through the 'Investor Relations' section of Senseonics' website at www.senseonics.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – SENS

-5.34%
1 alert
-5.34% News Effect

On the day this news was published, SENS declined 5.34%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

GERMANTOWN, Md., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming TD Cowen 45th Annual Health Care Conference, being held in Boston, MA.

TD Cowen 45th Annual Health Care Conference
Format: Corporate overview and one-on-one meetings
Date: Tuesday, March 4, 2025
Time: 3:10 pm ET
Webcast: Click here

Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

About Senseonics
Senseonics Holdings, Inc. ("Senseonics") is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems Eversense® 365 and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

Senseonics Investor Contact
Jeremy Feffer
LifeSci Advisors
investors@senseonics.com


FAQ

When is Senseonics (SENS) presenting at the TD Cowen Health Care Conference 2025?

Senseonics (SENS) is scheduled to present at the TD Cowen Health Care Conference on Tuesday, March 4, 2025, at 3:10 pm ET.

How can investors watch Senseonics' (SENS) presentation at the TD Cowen conference?

Investors can watch both the live and recorded webcasts of Senseonics' presentation through the 'Investor Relations' section of the company's website at www.senseonics.com.

What type of presentation will Senseonics (SENS) deliver at the TD Cowen conference?

Senseonics will deliver a corporate overview and conduct one-on-one meetings during the conference.

Where is the TD Cowen Health Care Conference featuring Senseonics (SENS) being held?

The TD Cowen 45th Annual Health Care Conference is being held in Boston, MA.
Senseonics

NASDAQ:SENS

View SENS Stock Overview

SENS Rankings

SENS Latest News

SENS Latest SEC Filings

SENS Stock Data

249.44M
37.07M
Medical Devices
Industrial Instruments for Measurement, Display, and Control
Link
United States
GERMANTOWN